89Bio, a clinical-stage biopharmaceutical company, today announced Thursday that the first patients have been screened in its proof of concept Phase 1b/2a clinical trial evaluating its... read more
Fri, 08/9/19 - 08:08 pm
Silk Road Medical recently filed the paperwork for a $159 Million public offering. The announcement comes not long after Silk Road raised $109 with its IPO in April of 2019.
The Sunnyvale... read more
Vida Ventures, which describes itself as a next-generation life sciences venture firm announced on 8/1/19 the closing of Vida Ventures II, LLC (“Vida II”),... read more
Vapotherm recently filed the paperwork for a new $57 Million offering. The company's HI-VNI technology provides maskless high velocity nasal insufflation for patients in respiratory distress or... read more
In a previous article (found here), we discussed the findings of a 2016 study that... read more